These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27914829)

  • 1. Life-threatening neuroleptic withdrawal emergent syndrome resembling status dystonicus.
    Pugin D; Bally J; Horvath J; Pollak P; Gasche Y; Burkhard PR
    Parkinsonism Relat Disord; 2017 Feb; 35():96-97. PubMed ID: 27914829
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic withdrawal.
    Maisami M; Golant D
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):336. PubMed ID: 1673122
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic withdrawal dyskinesia [proceedings].
    Escobar JI; Tuason VB
    Psychopharmacol Bull; 1979 Apr; 15(2):71-4. PubMed ID: 34845
    [No Abstract]   [Full Text] [Related]  

  • 4. Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine.
    Simpson DM; Davis GC
    Am J Psychiatry; 1984 Jun; 141(6):796-7. PubMed ID: 6145359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.
    Thomas A; Onofrj M
    Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099
    [No Abstract]   [Full Text] [Related]  

  • 6. Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.
    Connor DF; Benjamin S; Ozbayrak KR
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1490-4. PubMed ID: 8543517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The neuroleptic malignant syndrome].
    Duarte J; García Viejo MA; García Miguel FJ; Sempere AP
    Med Clin (Barc); 1994 Oct; 103(14):558. PubMed ID: 7799673
    [No Abstract]   [Full Text] [Related]  

  • 8. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
    Franks M; Macritchie KA; Mahmood T; Young AH
    J Psychopharmacol; 2008 Jun; 22(4):452-6. PubMed ID: 18635725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
    Eiden C; Capdevielle D; Deddouche C; Boulenger JP; Blayac JP; Peyrière H
    J Addict Med; 2011 Dec; 5(4):302-3. PubMed ID: 21817917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic withdrawal versus serotonergic syndrome in an 8-year-old child.
    Godinho EM; Thompson AE; Bramble DJ
    J Child Adolesc Psychopharmacol; 2002; 12(3):265-70. PubMed ID: 12427301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Quetiapine Withdrawal Syndrome with Nausea and Vomiting in a 65-year-old Patient with Psychotic Depression.
    Koch HJ
    Therapie; 2015; 70(6):537-8. PubMed ID: 26242495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome following levomepromazine discontinuation.
    Tanii H; Saka K; Inoue K; Okada M
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E16. PubMed ID: 20463130
    [No Abstract]   [Full Text] [Related]  

  • 16. The hypothesis of oestrogen withdrawal associated psychoses and the paradox of antipsychotic drug-induced hypoestrogenaemia.
    Baptista T; Beaulieu S
    Acta Psychiatr Scand; 2002 Jun; 105(6):473-4; author reply 474. PubMed ID: 12059854
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.
    Meltzer HY
    Arch Gen Psychiatry; 1995 Mar; 52(3):200-2. PubMed ID: 7872845
    [No Abstract]   [Full Text] [Related]  

  • 18. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
    Llorca PM; Vaiva G; Lancon C
    Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497
    [No Abstract]   [Full Text] [Related]  

  • 19. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L; Oepen G
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.